A shadow market for unlicensed weight-loss medications is being driven by social media fitness personalities and sellers on messaging platforms, according to recent findings.
Investigational Drug Gaining Popularity Via Social Media
The experimental drug, which remains in research studies, is being promoted by social media influencers for its supposed fat-burning properties. Viewers are encouraged to contact these accounts directly for source information, while also receiving discount codes.
Active Commerce on Social Networks
Separately, a robust market exists on Telegram, where groups with numerous of members share “before and after” images, administration instructions and claims of rapid UK delivery. Sellers promote the drug there before redirecting buyers to WhatsApp for transactions.
Learning About Retatrutide
This medication is an investigational injection created by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could help individuals reduce up to 25% of their body weight. Nicknamed the “triple G”, the substance is being promoted digitally as the successor to Ozempic.
Medical Experts Express Worries
Nevertheless, doctors and pharmacists have cautions that the sale of what remains an unlicensed drug in the UK is worrisome and could lead to individuals administering substances of unknown origin.
Several professionals said the demand for the experimental drug could be connected to the rising price of licensed slimming treatments such as Mounjaro.
Legal Position and Implementation
Selling the unapproved drug on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed drug that cannot be promoted or supplied for human use under the British medical regulations.
Several influencers attempt to circumvent the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and distribution can still violate medicines, marketing, and customer laws, risking penalties, prosecution or imprisonment.
Platform Response and Material Elimination
According to the social media company, the platform has removed problematic content and prohibited related keywords and query recommendations. The company said it was committed to maintaining the platform secure and allocating resources in enhancing compliance measures.
Online Trading Activities
Investigations also found groups with up to 9,000 members marketing retatrutide using the platform's built-in discovery tool, which operates like a online catalog. Typing “retatrutide” immediately brings up groups with thousands of members, filled with images of weight loss, glowing reviews and detailed instructions for mixing or injecting at residence.
Within minutes of joining one group, a vendor posted contact information, where most transactions occur. The seller provided an guidebook and guaranteed delivery within two days. When asked whether the substance was genuine, one vendor said: “You can’t be sure.” Another shared a image of a supposed testing documentation. None inquired about body mass, health issues or previous experience.
Product Information and Pricing
Inside these communities, messages show dark colored parcels with postal service labels, stating to contain new batches. One message read: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, mixed at home with sterile water, or pre-filled pens typically sold at £160 for 20 milligrams. When asked how much time a pen should be used, sellers give conflicting responses ranging from a several days to “depends on your body”.
Platform Moderation and Safety Actions
A representative for Telegram said it regularly monitored dangerous material on its platform including material that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Medical Professional Cautions
“Individuals are administering materials they can’t verify. Even if the research behind this drug is valid, these digital products may not include what they claim,” said a pharmacy expert, the director of pharmacy at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor linked the increase in interest to current price rises for authorized slimming drugs such as Mounjaro. “With costs rising, individuals are turning to online platforms. But counterfeit treatments are extremely dangerous. You can’t be certain what’s contained or whether the environment they were made in was clean,” she explained.
Her staff has already encountered individuals injured by self-injection from unconfirmed suppliers. “We recognize the frustration, but buying from Telegram or WhatsApp is gambling with your well-being,” said the doctor. “These substances could be contaminated or improperly measured.”
Producer Position
A representative from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been evaluated or approved by any regulatory agency globally. “Consequently at this point no one can market [it] for human use,” they said, adding that any item “misleadingly claiming itself as a company experimental substance not yet authorized … may subject users to potentially significant medical dangers”.
